Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3659 (MIR3659) is a small, non-coding RNA gene in humans that produces a mature microRNA molecule involved in RNA silencing and regulation of mRNA translation and stability[1][3]. MicroRNAs like MIR3659 function by recognizing complementary sequences in target mRNAs, primarily leading to translational inhibition or mRNA destabilization[1]. MIR3659 itself has no established direct role as a therapeutic target but has been studied as a down-regulated miRNA in prostate cancer, where its expression ratio against other miRNAs (such as miR-1913) provides biomarker potential for disease diagnosis[7]. Its detailed physiological and pathological roles remain to be fully elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3659 (MIR3659).